Abstract
Cartilage explant cultures and chondrocyte cultures have been routinely used to study the degradative mechanisms involved in joint destruction that lead to disease states such as osteoarthritis and rheumatoid arthritis. Stimulation of these culture systems with catabolic cytokines or chemical agents such as retinoic acid leads to an increase in the release of catabolites and enzymes into the culture medium. Detection of these catabolites using neoepitope antibodies can be used as indicators for the activity of degradative enzymes responsible for the breakdown of the tissue. Catabolites released include aggrecan interglobular domain (IGD) fragments, whereas enzymes include the aggrecanases (ADAMTS-4, TS-5, and-TS-1) as well as a number of matrix metalloproteinases. Monoclonal antibodies have been developed that specifically recognize the new N- and C-terminal amino acid sequences generated by aggrecanase cleavage of the IGD in aggrecan between 373E-374A (human sequence enumeration). These mouse monoclonal antibodies have been named BC-3 and BC-13 (1,2). BC-3 recognizes the new N-terminal sequence ARGSVIL... and BC-13 recognizes the new C-terminal...NITEGE in the IGD of aggrecan. These same amino acid sequences are not recognized in the intact molecule. Furthermore, the specific N- or C-terminal amino acid is essential for epitope recognition by these antibodies. Catabolites are separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane, which are then immuno-blotted with either the N- or C-terminal neoepitope antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Hughes, C. E., Caterson, B., Fosang, A. J., Roughley, P. J., and Mort, J. S. (1995) Monoclonal antibodies that specifically recognize neoepitope sequences generated by ‘aggrecanase’ and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem. J. 305, 799–804.
Little, C. B., Flannery, C., Hughes, C. E., Mort, J. S., Roughley, P. J., Dent, C., and Caterson, B. (1999) Aggrecanase versus matrix metalloproteinases in the interglobular domain catabolism of articular cartilage aggrecan in vitro. Biochem. J. 344, 61–68.
Vilim, V. and Fosang, A. J. (1994) Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterisation of naturally occurring hyaluronan-binding fragments of aggrecan. Biochem. J. 304, 887–894.
Tortorella, M. D., Pratta, M. A., Liu, R., Austin, J., Ross, O. H., Abbaszade, I., et al. (2000) Sites of cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem. 275, 18,566–18,573.
Hughes, C. E., Little, C. B., Büttner, F. H., Bartnik, E., and Caterson, B. (1998) Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage. J. Biol. Chem. 273, 30,576–30,582.
Sandy, J., Gamett, D., Thompson, V., and Verscharen, C. (1998) Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem. J. 335, 59–66.
Kashiwagi, M., Tortorella, M., Nagase, H., and Brew, K. (2001) TIMP-3 is a potent inhibitor of ADAMTS-4 (Aggrecanase 1) and ADAMTS-5 (Aggrecanase2). J. Biol. Chem. 276, 12,501–12,504.
Sztrolovics, R., White, R., Poole, A., Mort, J., and Roughley, P. (1999). Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem. J. 339, 571–577.
Billington, C., Clark, I., and Cawston, T. (1998) An aggrecan-degrading activity associated with chondrocyte membranes. Biochem. J. 336, 207–212.
Vankemmelbeke, M., Ilic, M., Handley, C., Knight, C., and Buttle, D. (1999) Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble “Aggrecanase” activity. Biochem. Biophys. Res. Commun. 255, 686–691.
Sandy, J. D. and Verscharen, C. (2001) Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J. 358, 615–626.
Cai, L., Yin, J., Starovasnik, M., Hogue, D., Hillan, K., Mort, J., and Filvaroff, E. (2001). Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine. 16, 10–21.
Lark, M. W., Gordy, J. T., Weidner, J. R., Ayala, J., Kimura, J. H., Williams, H. R., et al. (1995) Cell-mediated catabolism of aggrecan. Evidence that cleavage at the “aggrecanase” site (Glu 373-Ala 374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270, 2550–2556.
Sztrolovics, R., Alini, M., Roughley, P. J., and Mort, J. S. (1997) Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem. J. 326, 235–241.
Sugimoto, K., Takahashi, M., Yamamoto, Y., Shimada, K., and Tanzawa, K. (1999). Identification of aggrecanase activity in medium of cartilage culture. J. Biochem. 126, 449–455.
Mercuri, F. A., Doege, K. J., Arner, E. C., Pratta, M. A., Last, K., and Fosang, A. J. (1999) Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase. J. Biol. Chem. 274, 32,387–32,395.
Bayliss, M., Hutton, S., Hayward, J., and Maciewicz, R. (2001) Distribution of aggrecanase (ADAMts 4/5) cleavage products in normal and osteoarthritic human articular cartilage: the influence of age, topography and zone of tissue. Osteoarthritis Cartilage 9, 553–560.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Hughes, C.E., Little, C.B., Caterson, B. (2003). Measurement of Aggrecanase-Generated Interglobular Domain Catabolites in the Medium and Extracts of Cartilage Explants Using Western Blot Analysis. In: Winyard, P.G., Willoughby, D.A. (eds) Inflammation Protocols. Methods in Molecular Biology, vol 225. Humana Press. https://doi.org/10.1385/1-59259-374-7:89
Download citation
DOI: https://doi.org/10.1385/1-59259-374-7:89
Publisher Name: Humana Press
Print ISBN: 978-0-89603-970-4
Online ISBN: 978-1-59259-374-3
eBook Packages: Springer Protocols